- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| XEBRA BRANDS Aktie jetzt für 0€ handeln | |||||
| 19.09. | Xebra Brands Ltd (2): Xebra's 1:10 rollback to be delayed until CTO revoked | 3 | Stockwatch | ||
| 19.09. | Xebra Brands Ltd: Xebra Brands Announces Update on Share Consolidation | 217 | ACCESS Newswire | VANCOUVER, BC / ACCESS Newswire / September 19, 2025 / Xebra Brands Ltd. ("Xebra") (CSE:XBRA)(FSE:9YC), an international cannabis company, announces that, its previously announced (August 15, 2025,... ► Artikel lesen | |
| 13.09. | Xebra Brands Ltd (2): Xebra Brands to roll back shares one for 10 Sept. 19 | 3 | Stockwatch | ||
| 13.09. | Xebra Brands Ltd: Xebra Brands Announces Update on Share Consolidation | 443 | ACCESS Newswire | VANCOUVER, BC / ACCESS Newswire / September 12, 2025 / Xebra Brands Ltd. ("Xebra") (CSE:XBRA)(FSE:9YC), an international cannabis company, announces that, its previously announced (August 15, 2025)... ► Artikel lesen | |
| 04.09. | CSE Bulletin: Suspension - XEBRA Brands Ltd. (XBRA) | 316 | Newsfile | Toronto, Ontario--(Newsfile Corp. - Le 4 septembre/September 2025) - Effective immediately, XEBRA Brands Ltd. is suspended pursuant to CSE Policy 3. The suspension is considered a Regulatory Halt... ► Artikel lesen | |
| 04.09. | Xebra Brands Ltd (2): Xebra Brands suspended by CSE | 3 | Stockwatch | ||
| 04.09. | XFRA 9YC0: AUSSETZUNG/SUSPENSION | 240 | Xetra Newsboard | DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILXEBRA BRANDS CL.A... ► Artikel lesen | |
| 22.08. | Xebra Brands Ltd (2): Xebra Brands to be late to file fiscal 2025 results | 1 | Stockwatch | ||
| 22.08. | Xebra Brands Ltd: Xebra Brands Announces Issuance of Cease Trade Order | 405 | ACCESS Newswire | VANCOUVER, BC / ACCESS Newswire / August 22, 2025 / Xebra Brands Ltd. ("Xebra" or the "Company") (XBRA:CSE)(XBRAF:OTC PINK)(9YC:FSE), a cannabis company, announces that the Company does not expect to... ► Artikel lesen | |
| 16.08. | Xebra Brands Ltd: Xebra Brands Announces Share Consolidation and Provides Update on MCTO | 549 | ACCESS Newswire | VANCOUVER, BC / ACCESS Newswire / August 15, 2025 / Xebra Brands Ltd. ("Xebra") (CSE:XBRA)(FSE:9YC), a international cannabis company, announces that it intends to consolidate its issued and outstanding... ► Artikel lesen | |
| 02.08. | Xebra Brands Ltd (2): Xebra Brands has no material changes | 2 | Stockwatch | ||
| 02.08. | Xebra Brands Ltd: Xebra Provides Update on MCTO | 716 | ACCESS Newswire | VANCOUVER, BC / ACCESS Newswire / August 1, 2025 / Xebra Brands Ltd. ("Xebra") (CSE:XBRA)(OTC PINK:XBRAF)(FSE:9YC), an international cannabis company, is providing an update to its previously disclosed... ► Artikel lesen | |
| 16.07. | Xebra Brands Ltd (2): Xebra hopes to file fiscal 2025 financials by Aug. 29 | 3 | Stockwatch | ||
| 16.07. | Xebra Brands Ltd: Xebra Provides Update on Management Cease Trade Order | 253 | ACCESS Newswire | VANCOUVER, BC / ACCESS Newswire / July 16, 2025 / Xebra Brands Ltd. ("Xebra") (CSE:XBRA)(OTCQB:XBRAF)(FSE:9YC), an international cannabis company, is providing an update to its previously disclosed... ► Artikel lesen | |
| 03.07. | Xebra Brands Ltd (2): Xebra Brands cancels LOI to acquire BSK | 5 | Stockwatch | ||
| 03.07. | Xebra Brands Ltd. Terminates Letter of Intent to Acquire BSK Holdings Inc.; Announces Delay in Completion of Annual Filings and MCTO; Announces Loan | 424 | ACCESS Newswire | Continued Partnership to Bring ELEMENTS CBD Product Line to U.S. Market VANCOUVER, BC / ACCESS Newswire / July 2, 2025 / Xebra Brands Ltd. ("Xebra" or the "Company") (CSE:XBRA)(OTCQB:XBRAF)(FSE:9YC0)... ► Artikel lesen | |
| 24.06. | Xebra Brands Ltd (2): Xebra Brands clarifies not-yet-granted MCTO | 7 | Stockwatch | ||
| 23.06. | Xebra Brands Ltd: Xebra Announces Corporate Update and Correction Notice of Press Release Announcing Grant of Management Cease Trade Order | 418 | ACCESS Newswire | VANCOUVER, BC / ACCESS Newswire / June 23, 2025 / Xebra Brands Ltd. (CSE:XBRA) (the "Company" or "Xebra Brands") announces a correction to the Company's press release dated June 23, 2025 announcing... ► Artikel lesen | |
| 23.06. | Xebra Brands Ltd (2): Xebra Brands to be late to file fiscal 2025 results | 2 | Stockwatch | ||
| 23.06. | Xebra Brands Ltd: Xebra Announces Delay in Filing Financial Statements | 298 | ACCESS Newswire | VANCOUVER, BC / ACCESS Newswire / June 23, 2025 / Xebra Brands Ltd. ("Xebra") (XBRA:CSE)(XBRAF:OTCQB)(9YC:FSE), announces today that it was not in a position to file its audited annual financial statements... ► Artikel lesen |
1 2 Weiter >>
36 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| BAYER | 28,625 | +4,36 % | Bayer mit Lebenszeichen! Aktie vor neuer Rallye? | Der Chemie- und Pharma-Riese zeigt sich im dritten Quartal mit operativen Verbesserungen. Genügt das, um Bewegung in das zuletzt lahme Kursgeschehen zu bringen? Bayer kommt nach wie vor nur langsam... ► Artikel lesen | |
| AURORA CANNABIS | 4,000 | +1,65 % | Aurora Cannabis Inc.: Aurora Cannabis Announces Fiscal 2026 Second Quarter Results | Expands YoY Global Medical Cannabis Net Revenue 1 by 15% to Record $70.5 million
Increases International Medical Cannabis Net Revenue 1 by 22% to... ► Artikel lesen | |
| CANOPY GROWTH | 1,042 | +0,97 % | Cannabis-Aktien im Fokus: Canopy Growth und Bioxyne - alles dreht sich um strategische Umsetzung! | ||
| TILRAY BRANDS | 1,125 | +0,63 % | Tilray Brands, Inc.: Tilray Brands Condemns Misguided Prohibitionist Measures and Champions Responsible Hemp Regulations that Keep Consumers Safe and Businesses Thriving | NEW YORK, Nov. 11, 2025 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. ("Tilray Brands" or "Tilray") (Nasdaq: TLRY; TSX: TLRY), a global lifestyle and consumer packaged goods company at the forefront of... ► Artikel lesen | |
| INNOCAN PHARMA | 10,100 | +2,54 % | InnoCan Pharma: Nasdaq-IPO-Countdown! | ||
| CRONOS GROUP | 2,138 | -1,57 % | Cronos signals revenue boost potential with 70% flower capacity increase amid international momentum | ||
| SYNBIOTIC | 2,375 | -0,21 % | EQS-News: SYNBIOTIC SE: SYNBIOTIC begrüßt Antrag der Grünen zum Nutzhanfliberalisierungsgesetz und fordert Sachlichkeit in der Medizinalcannabis-Debatte | EQS-News: SYNBIOTIC SE
/ Schlagwort(e): Stellungnahme
SYNBIOTIC begrüßt Antrag der Grünen zum Nutzhanfliberalisierungsgesetz und fordert Sachlichkeit in der Medizinalcannabis-Debatte... ► Artikel lesen | |
| NEKTAR THERAPEUTICS | 52,00 | +0,97 % | Nektar Therapeutics Reports Third Quarter 2025 Financial Results | SAN FRANCISCO, Nov. 6, 2025 /PRNewswire/ -- Nektar Therapeutics (Nasdaq: NKTR) today reported financial results for the third quarter ended September 30, 2025.
Cash... ► Artikel lesen | |
| ORAMED PHARMACEUTICALS | 2,047 | -2,24 % | Patientenwohl als Schlüssel zu Rendite: Oramed Pharmaceutials, Roche, BioNxt | Höher, schneller, weiter - nicht nur im Sport kommt es auf ständigen Fortschritt an. Auch in Wirtschaft und Wissenschaft geht es um stete Innovationen und Verbesserungen. Die Biotechnologie vereint... ► Artikel lesen | |
| OPKO HEALTH | 1,125 | -1,63 % | OPKO Health, Inc.: OPKO Health Reports Third Quarter 2025 Business Highlights and Financial Results | MIAMI, Oct. 29, 2025 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) (OPKO) reports business highlights and financial results for the three and nine months ended September 30, 2025. Highlights... ► Artikel lesen | |
| JAGUAR HEALTH | 1,740 | 0,00 % | Jaguar Health, Inc.: Initial Groundbreaking Results of Proof-of-Concept Study of Jaguar Health's Crofelemer for Treatment of Pediatric Intestinal Failure to be Presented November 8, 2025 at North American Society for Pediatric Gastroenterology | Results of ongoing investigator-initiated proof-of-concept trial of crofelemer in United Arab Emirates (UAE) demonstrate disease progression modification and reduction of total parenteral support (PS)... ► Artikel lesen | |
| SELLAS LIFE SCIENCES | 1,272 | -2,15 % | SELLAS Life Sciences Group, Inc.: SELLAS Life Sciences Announces Independent Data Monitoring Committee Periodic Review and Positive Recommendation to Continue Pivotal Phase 3 REGAL Trial of GPS in AML Without Modification | - Final Analysis Anticipated by Year-End Upon Occurrence of 80 Events - NEW YORK, Aug. 07, 2025 (GLOBE NEWSWIRE) -- SELLAS Life Sciences Group, Inc. (NASDAQ: SLS) ("SELLAS'' or the... ► Artikel lesen | |
| XORTX THERAPEUTICS | 0,492 | -3,91 % | XORTX Therapeutics Inc.: XORTX Announces Closing of US$1.1 Million Registered Direct Offering | CALGARY, Alberta, Oct. 29, 2025 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. ("XORTX" or the "Company") (NASDAQ: XRTX | TSXV: XRTX | Frankfurt: ANU), a late-stage clinical pharmaceutical company focused... ► Artikel lesen | |
| NUMINUS WELLNESS | 0,027 | -100,00 % | Numinus Wellness Inc.: Numinus Wellness Announces Change of Auditor | Vancouver, British Columbia--(Newsfile Corp. - October 10, 2025) - Numinus Wellness Inc. (TSX: NUMI) (OTCQB: NUMIF) ("Numinus" or the "Company"), a mental health care company focused on innovative... ► Artikel lesen | |
| TALPHERA | 1,094 | +1,67 % | Earnings Outlook For Talphera |
XEBRA BRANDS LTD gehört der Branche Pharma an. Mit einer aktuellen Kursveränderung von -0,008 (-100,00 %) liegt der Kurs bei 0,008 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu XEBRA BRANDS LTD finden Sie auf Wallstreet Online.